Roger Owens

We are delighted to introduce Roger R. Owens, MS as our Chief Commercial Officer at Ultromics. Hailing from the United States and based in Dallas, Roger assumes a pivotal role in driving the global commercial strategy that shapes the trajectory of our organization.

With an impressive career spanning over 25+ years in the Cardiovascular MedTech industry, Roger has demonstrated his prowess in navigating commercial landscapes within both established MedTech giants at the senior staff level and dynamic startup environments. His extensive expertise encompasses Cardiac Rhythm Management, Electrophysiology, Coronary and Endovascular care, as well as Vessel Closure and Structural Heart businesses.

Roger's impactful contributions have left a lasting imprint on esteemed companies such as Guidant, Boston Scientific, Abbott, and, most recently, Chief Commercial Officer of Cardiva, which was acquired in 2021 prior to going public. With this proven track record, we foresee his instrumental role in steering Ultromics towards continued success in the dynamic MedTech arena.

Roger holds a Bachelor of Science degree in Biomedical Science, Bachelor of Arts degree in Psychology, and a Masters of Science in Cardiac Physiology all from Ohio University.